See how an innovative vector design can simplify cell line development workflows, improve productivity without compromising product quality and enable DNA-to-IND in as little as 6 months.
You may also be interested in:
Bispecific Antibody
Difficult to Express Proteins
GS Ori-Go® Vectors
Cell Line Development
Watch this video
Watch now
Latest briefing from the Knowledge Center
Video
Rethinking Cell Line Development with GS Ori-Go® Technology
See how an innovative vector design can simplify cell line development workflows, improve...
e-book
Advancing Biologics with Confidence
For emerging biotech companies, every milestone matters. Limited resources, investor...
Article
4,000L Microbial Fermentation Capacity
Providing full scale-up options for Lonza’s customers to navigate the entire product life...
Poster
From iPSC Discovery to Commercial Reality: Manufacturing Lessons For Enabling Clinical and...
Advancing induced pluripotent stem cell (iPSC)-based therapies requires more than scientific...
Article
How Greater Value Built into Every Biologics Batch Helps Deliver Optimized Manufacturing Economics
What does a 20 kL bioreactor really mean? At Lonza, it means 20 kL of effective working...
R&D Blog post
Challenging assumptions: The journey behind the GS Ori-Go® vector system
If there’s one lesson I’ve learned throughout my scientific career, it’s that some of the most...
White paper
Accelerate the Timeline from Gene to Lead Clone with New GS Ori-Go® Vectors
Drug developers face tremendous pressure to increase efficiency and productivity, and reduce...
Peer-reviewed publication
Next‐Generation Glutamine Synthetase Expression Vector for Therapeutic Protein Manufacturing Using...
The glutamine synthetase expression system is widely used for therapeutic protein biomanufacturing...
Webinar (on-demand)
Development of Fit-For-Purpose In Vivo LVV Manufacturing Process
The transition of lentiviral vectors (LVVs) from an ex vivo manufacturing tool to a directly...
Webinar (on-demand)
One Partner for Your Entire ADC Journey
The path from ADC development to commercial manufacturing is becoming increasingly complex,...
Webinar (on-demand)
IND in as Little as 6 Months: Now Beyond mAbs
As pressure to reach critical development milestones faster continues to grow, sponsors are seeking...
Article
Viral Vector Production: How CDMOs Influence Late-Stage Development Success
Viral cell and gene therapies (CGT) have transformed modern medicine by offering durable, and in...